Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. 10x Genomics Inc shares valued at $91,612 were sold by Saxonov Serge on Nov 22 ’24. At $13.69 per share, Saxonov Serge sold 6,693 shares. The insider’s holdings dropped to 872,574 shares worth approximately $11.71 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hindson Benjamin J. sold 5,807 shares, netting a total of over 79,485 in proceeds. Following the sale of shares at $13.69 each, the insider now holds 339,897 shares.
Before that, Hindson Benjamin J. had added 5,734 shares to its account. In a trade valued at $76,377, the Officer bought 10x Genomics Inc shares for $13.32 each.
As published in their initiating research note from Leerink Partners on September 03, 2024, 10x Genomics Inc [TXG] has been an Outperform and the price target has been revised to $35. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late July. As of July 18, 2024, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for TXG. Earlier on July 10, 2024, Deutsche Bank downgraded its rating. Their new recommendation was “a Hold” for TXG stock which previously was a “a Buy”.
Analyzing TXG Stock Performance
During the last five days, there has been a drop of approximately -16.54%. Over the course of the year, 10x Genomics Inc shares have dropped approximately -76.02%. Shares of the company reached a 52-week high of $55.96 on 01/02/24 and a 52-week low of $12.95 on 11/19/24. A 50-day SMA is recorded $15.48, while a 200-day SMA reached $22.57. Nevertheless, trading volume fell to 1.92 million shares from 1.13 million shares the previous day.
Support And Resistance Levels for 10x Genomics Inc (TXG)
According to the 24-hour chart, there is a support level at 12.76, which, if violated, would cause prices to drop to 12.11. In the upper region, resistance lies at 14.48. The next price resistance is at 15.55. RSI (Relative Strength Index) is 37.24 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.05, which suggests the price will decrease in the coming days. Percent R is at 92.98%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
